Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peptide vaccination (STF-II) in advanced esophageal squamous cell carcinoma
NCT01267578Phase 2Unknown
- Sponsor
- University of Yamanashi
- Start
- Apr 2010
- Primary completion
- May 2011
- Modality
- Peptides, Peptide-based Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of URLC10, CDCA1-64 in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by University of Yamanashi. Status: unknown.
02
Drugs
URLC10CDCA1-64
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT01267578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01267578.